26.10.2017 • NewsDede WillamsLyondellBasellPE

LyondellBasell Plans new US Gulf Project

(c) Lyondellbasell
(c) Lyondellbasell

Netherlands-headquartered, US-managed LyondellBasell is planning to build a new chemicals and plastics complex on the Gulf Coast, CEO Bob Patel has told the Texas newspaper Houston Chronicle.

In the executive’s well observed habit of launching trial balloons well in advance, the newspaper quotes Patel as saying a final decision may still be a year away.

The planned facility, he said, would be the world’s largest to produce propylene oxide and butyl alcohol, with capacity to turn out 1 billion lbs and 2.2 billion lbs respectively (454,000 t of the former and about 1 million t of the latter).

Patel said he hopes to move forward with the plans by the end of 2018.

LyondellBasell has already implemented a major expansion along the Houston Ship Channel and has broken ground for its new 500,000 t/y PE plant at its La Porte petrochemical complex near Houston. That facility is set for start-up in 2019.

The CEO told the Chronicle that propane as a feedstock is less cost advantaged than ethane but ihe new facility would meet growing US demand for polypropylene as a plastic and fabric. One important market would be the automotive industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.